Jefferies upgrades Chemed to Buy and lifts price target to $620
Jefferies upgraded Chemed to Buy from Hold and raised its price target to $620. For OneSpaWorld, the Buy rating is kept and the target rises to $40.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Jefferies analysts upgraded Chemed (CHE) shares from Hold to Buy and raised the price target from $520 to $620 per share. Dow Jones Newswires reported the revision, citing Benzinga.
The same evening, Jefferies lifted its price target on OneSpaWorld (OSW) from $36 to $40 per share and kept its Buy rating. Both updates were published at 22:18 and 22:29 GMT on October 28, 2026.
why it matters
Rating changes on individual stocks usually affect only those shares and rarely move the broader market. For investors in these names, the trend in analyst valuations is the main takeaway.
tags
instruments
sources
- Chemed Price Target Raised to $620.00/Share From $520.00 by Jefferies — Dow Jones Newswires, 28 October 2026 at 22:18 UTC
- OneSpaWorld Price Target Raised to $40.00/Share From $36.00 by Jefferies — Dow Jones Newswires, 28 October 2026 at 22:29 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗